BRIDGE INVESTMENT GRP HDS-A (BRDG) Stock Fundamental Analysis
USA - NYSE:BRDG - US10806B1008 - Common Stock
9.6 USD
-0.04 (-0.41%)
9.6 USD
0 (0%)
BRDG gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 238 industry peers in the Capital Markets industry. BRDG has a bad profitability rating. Also its financial health evaluation is rather negative. BRDG has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year BRDG was profitable.
In the past year BRDG had a positive cash flow from operations.
BRDG had positive earnings in 4 of the past 5 years.
In the past 5 years BRDG always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of BRDG (-1.34%) is worse than 79.08% of its industry peers.
With a Return On Equity value of -21.07%, BRDG is not doing good in the industry: 82.85% of the companies in the same industry are doing better.
BRDG has a worse Return On Invested Capital (2.53%) than 63.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.34% | ||
| ROE | -21.07% | ||
| ROIC | 2.53% |
ROA(3y)5.12%
ROA(5y)15.94%
ROE(3y)74.02%
ROE(5y)130.59%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Profit Margin of BRDG has declined.
BRDG has a worse Operating Margin (7.94%) than 69.46% of its industry peers.
In the last couple of years the Operating Margin of BRDG has declined.
The Profit Margin and Gross Margin are not available for BRDG so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.94% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3Y-50.22%
OM growth 5Y-31.37%
PM growth 3Y-69.93%
PM growth 5Y-52.56%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
Compared to 1 year ago, BRDG has more shares outstanding
Compared to 5 years ago, BRDG has more shares outstanding
The debt/assets ratio for BRDG has been reduced compared to a year ago.
2.2 Solvency
BRDG has an Altman-Z score of 1.01. This is a bad value and indicates that BRDG is not financially healthy and even has some risk of bankruptcy.
BRDG has a Altman-Z score (1.01) which is comparable to the rest of the industry.
The Debt to FCF ratio of BRDG is 4.71, which is a neutral value as it means it would take BRDG, 4.71 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.71, BRDG is in the better half of the industry, outperforming 69.04% of the companies in the same industry.
BRDG has a Debt/Equity ratio of 5.97. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 5.97, BRDG is doing worse than 87.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.97 | ||
| Debt/FCF | 4.71 | ||
| Altman-Z | 1.01 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
BRDG has a Current Ratio of 0.73. This is a bad value and indicates that BRDG is not financially healthy enough and could expect problems in meeting its short term obligations.
BRDG has a Current ratio of 0.73. This is in the lower half of the industry: BRDG underperforms 66.11% of its industry peers.
BRDG has a Quick Ratio of 0.73. This is a bad value and indicates that BRDG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BRDG (0.73) is worse than 65.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.73 | ||
| Quick Ratio | 0.73 |
3. Growth
3.1 Past
The earnings per share for BRDG have decreased strongly by -22.22% in the last year.
BRDG shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -36.67% yearly.
The Revenue has grown by 17.00% in the past year. This is quite good.
BRDG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.67% yearly.
EPS 1Y (TTM)-22.22%
EPS 3Y-61.36%
EPS 5Y-36.67%
EPS Q2Q%-26.32%
Revenue 1Y (TTM)17%
Revenue growth 3Y-14.88%
Revenue growth 5Y4.67%
Sales Q2Q%-95.7%
3.2 Future
The Earnings Per Share is expected to decrease by -34.51% on average over the next years. This is quite bad
The Revenue is expected to grow by 19.65% on average over the next years. This is quite good.
EPS Next Y18.26%
EPS Next 2Y24.78%
EPS Next 3Y-34.51%
EPS Next 5YN/A
Revenue Next Year30.19%
Revenue Next 2Y30.88%
Revenue Next 3Y19.65%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 17.14, the valuation of BRDG can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of BRDG is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.70, BRDG is valued a bit cheaper.
BRDG is valuated reasonably with a Price/Forward Earnings ratio of 8.94.
BRDG's Price/Forward Earnings ratio is rather cheap when compared to the industry. BRDG is cheaper than 83.26% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BRDG to the average of the S&P500 Index (23.15), we can say BRDG is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.14 | ||
| Fwd PE | 8.94 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BRDG is valued a bit cheaper than 64.02% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BRDG is valued a bit cheaper than 66.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.57 | ||
| EV/EBITDA | 29.96 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A cheap valuation may be justified as BRDG's earnings are expected to decrease with -34.51% in the coming years.
PEG (NY)0.94
PEG (5Y)N/A
EPS Next 2Y24.78%
EPS Next 3Y-34.51%
5. Dividend
5.1 Amount
BRDG has a Yearly Dividend Yield of 1.88%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 8.50, BRDG is paying slightly less dividend.
BRDG's Dividend Yield is slightly below the S&P500 average, which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.88% |
5.2 History
BRDG has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of BRDG are negative and hence is the payout ratio. BRDG will probably not be able to sustain this dividend level.
DP-91.83%
EPS Next 2Y24.78%
EPS Next 3Y-34.51%
9.6
-0.04 (-0.41%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners53.84%
Inst Owner Change0%
Ins Owners14.86%
Ins Owner Change-27816.8%
Market Cap1.20B
Analysts45.71
Price Target9.95 (3.65%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.88% |
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DP-91.83%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-36.73%
Min EPS beat(2)-45.7%
Max EPS beat(2)-27.76%
EPS beat(4)1
Avg EPS beat(4)-20.71%
Min EPS beat(4)-45.7%
Max EPS beat(4)8.93%
EPS beat(8)4
Avg EPS beat(8)-12.55%
EPS beat(12)5
Avg EPS beat(12)-21.02%
EPS beat(16)9
Avg EPS beat(16)8.19%
Revenue beat(2)1
Avg Revenue beat(2)-36.5%
Min Revenue beat(2)-94.66%
Max Revenue beat(2)21.66%
Revenue beat(4)3
Avg Revenue beat(4)-6.78%
Min Revenue beat(4)-94.66%
Max Revenue beat(4)25.82%
Revenue beat(8)6
Avg Revenue beat(8)2.79%
Revenue beat(12)10
Avg Revenue beat(12)8.78%
Revenue beat(16)14
Avg Revenue beat(16)53.84%
PT rev (1m)-2.5%
PT rev (3m)-2.5%
EPS NQ rev (1m)3.28%
EPS NQ rev (3m)-1.87%
EPS NY rev (1m)4.92%
EPS NY rev (3m)-1.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.75%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.14 | ||
| Fwd PE | 8.94 | ||
| P/S | 2.88 | ||
| P/FCF | 12.57 | ||
| P/OCF | 12.56 | ||
| P/B | 15.94 | ||
| P/tB | N/A | ||
| EV/EBITDA | 29.96 |
EPS(TTM)0.56
EY5.83%
EPS(NY)1.07
Fwd EY11.19%
FCF(TTM)0.76
FCFY7.96%
OCF(TTM)0.76
OCFY7.96%
SpS3.33
BVpS0.6
TBVpS-2.2
PEG (NY)0.94
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.34% | ||
| ROE | -21.07% | ||
| ROCE | 3.2% | ||
| ROIC | 2.53% | ||
| ROICexc | 2.72% | ||
| ROICexgc | 4.73% | ||
| OM | 7.94% | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | 22.93% |
ROA(3y)5.12%
ROA(5y)15.94%
ROE(3y)74.02%
ROE(5y)130.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-55.19%
ROICexcg growth 5Y-44.29%
ROICexc growth 3Y-62.42%
ROICexc growth 5Y-49.03%
OM growth 3Y-50.22%
OM growth 5Y-31.37%
PM growth 3Y-69.93%
PM growth 5Y-52.56%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.97 | ||
| Debt/FCF | 4.71 | ||
| Debt/EBITDA | 8.54 | ||
| Cap/Depr | 0.55% | ||
| Cap/Sales | 0.03% | ||
| Interest Coverage | 1.39 | ||
| Cash Conversion | 181.69% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.73 | ||
| Quick Ratio | 0.73 | ||
| Altman-Z | 1.01 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)41.9%
Cap/Depr(5y)34.87%
Cap/Sales(3y)0.51%
Cap/Sales(5y)0.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.22%
EPS 3Y-61.36%
EPS 5Y-36.67%
EPS Q2Q%-26.32%
EPS Next Y18.26%
EPS Next 2Y24.78%
EPS Next 3Y-34.51%
EPS Next 5YN/A
Revenue 1Y (TTM)17%
Revenue growth 3Y-14.88%
Revenue growth 5Y4.67%
Sales Q2Q%-95.7%
Revenue Next Year30.19%
Revenue Next 2Y30.88%
Revenue Next 3Y19.65%
Revenue Next 5YN/A
EBIT growth 1Y529.53%
EBIT growth 3Y-57.63%
EBIT growth 5Y-28.16%
EBIT Next Year-20.88%
EBIT Next 3Y14.63%
EBIT Next 5YN/A
FCF growth 1Y-38.52%
FCF growth 3Y-11.33%
FCF growth 5Y-0.9%
OCF growth 1Y-40%
OCF growth 3Y-11.46%
OCF growth 5Y-1.1%